Optogenetics Market size is expected to grow at a CAGR of 16.2% during the forecast period and the market size is expected to reach nearly US$ 78.57 Bn. by 2027.Optogenetics Market Product Definition
Optogenetics is a neuromodulation method that uses a combination of gene-tics and optics techniques to control and monitor activities of cells in a living tissue with light. Optogenetics very usually refers to a biological technique that includes the usage of light to control neurons that have been genetically modified to express light-sensitive ion channels. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.To know about the Research Methodology :- Request Free Sample Report
Optogenetics Market Dynamics
The Research Report gives a comprehensive account of the drivers and restraints in the optogenetics market. This technique allows researchers to study the neurological activity patterns within specific brain cells and gives rise to thoughts, behaviors, and memories at an unprecedented precision level. In this way, it helps to find cures and treatments for neurological and psychiatric disorders, such as Neural dysfunction, which causes Parkinson’s disease, anxiety, mood disorders, depression, memory disorders, addiction, cardiac disorders, and others can be altered and cured by Optogenetics. Developed research in the field of ophthalmology and neuroscience is anticipated to impel the market. Different initiatives are undertaken by worldwide organizations such as, NIH and WHO are also projected to compel the market growth rate. Factors responsible for the growth of the optogenetics market are upsurge in liability of retinal disease and neurological disorders, prompt development and research in the field of optogenetics, and government initiatives like funding support for the growth of this field. Optogenetics help to understand which physiological and biochemical pathway is working for the cause of specific disease, which may support to find treatment for the specific disease by flashing blue light on specific neural cells. Improvement and technical developments in toolsets like neural connectivity, neural recording and imaging tools cell phenotyping tools, have further boosted and aided the growth of the optogenetics market in neuroscience. According to the World Health Organization’s factsheet in 2019, age-related macular degeneration (AMD) ranked third among the global causes of visual impairment with a blindness prevalence of at least 2.2 billion. Age-related macular degeneration is the primary cause of visual deficiency in industrialized countries. Alzheimer’s disease is another potential area in which optogenetics could give a sustainable treatment solution. According to the World Alzheimer Report in 2019, there were an estimated 50 million Alzheimer’s disease patients across the world, a figure set to increase to 152 million by 2050. Besides, every three seconds, one new case of Alzheimer’s disease is registered, worldwide.Optogenetics Market Restraints:
Optogenetics Market High Cost of Technology The optogenetics market is extremely confined by the cost of technology. The technical developments in the field of LEDs and laser devices are irregularly raising the cost of accessory devices, and therefore, the overall cost of technology. Actuators and sensors are also in the phase of development with novel and further technically proficient ones being developed by several labs, which might more contribute to the cost of technology. Ethical guidelines for animal welfare, which is probable to affect the market growth rate.Optogenetics Market Segment Analysis
Based on light equipment, the Light Emitting Diode (LEDs) segment is expected to grow at a CAGR of XX% during the forecast period. LEDs are found to better lasers as they are inexpensive, minor, more dependable, and easier to control. LEDs are being incorporated into implants, permitting released light delivery. On the other hand, a recent class of fiber-coupled LEDs offers much higher intensities of fiber-coupled light. Hence, there is ample improvement, in both LED technologies and their applications. Effective LED therapies are used in treating cutaneous and neurological diseases. The researchers in LEDs, imaging, light therapy, and optogenetics have understood the basic principles, and hence, they are promoting the applications of LEDs in healthcare.Optogenetics Market Regional Analysis
The North American region has dominated the market with US$ xx Mn. Most of the optogenetics associated research is ongoing in the U.S., which is why it serves as a favorable environment for the growth of the market. There is robust government funding to carry research and development in this field as optogenetics has probable to better understand pathophysiology in a chronic neural disease like Alzheimer’s disease and Parkinson’s disease, which has high incidence rate in the U.S. National Institute of Mental Health of the National Institutes of Health (NIH) in 2016, awarded a grant of US$ 1.4 million to Max Planck Florida Institute for Neuroscience and NYU Langone Medical Center for research in optogenetics. Companies such as GenSight Biologics have their optogenetics research platform GS030 in the preclinical stage. There are several advancements in neuroscience that are made possible by the BRAIN initiative (Brain Research through Advancing Innovative Neurotechnologies), a huge, co-operative, private-public funded scheme intended at better understanding the human brain. The objective of the report is to present a comprehensive analysis of the Global Optogenetics Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Optogenetics Market dynamics, structure by analysing the market segments and projects the Global Optogenetics Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Optogenetics Market make the report investor’s guide.Optogenetics Market Scope: Inquire before buying
Global Optogenetics Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 23.64 Bn. Forecast Period 2022 to 2029 CAGR: 16.2% Market Size in 2029: US $ 78.57 Bn. Segments Covered: by Sensors • Genetically Modified Calcium Indicators • pH Sensors • Neurotransmitter Release • Voltage-sensitive Fluorescent Proteins by Techniques • Channelrhodopsin • Halorhodopsin • Archaerhodopsin by Application • Retinal Disease Treatment • Cardiovascular Ailments • Neuroscience • Behavioral Tracking and Pacing by Light Equipment • Lasers • LEDs • Others Optogenetics Market, by Regions
• North America • Europe • Asia-Pacific • South America • Middle East and Africa (MEA)Optogenetics Market, Key Players
• Cobolt • Coherent Inc. • Gensight Biologics • Laserglow Technologies • Noldus Information Technology • Scientifica • Shanghai Laser & Optics Century Co. Ltd. • The Jackson Laborator • Thorlabs Inc. • Thomas RECORDING GmbH • UNC Vector Core • Addgene • Elliot Scientific Ltd. • Danaher • Prizmatix • Bruker • Judges Scientific plc • Merck KGaA • Circuit Therapeutics, Inc.Frequently Asked Questions:
1. Which region has the largest share in Global Optogenetics Market? Ans: North America region holds the highest share in 2021. 2. What is the growth rate of Global Optogenetics Market? Ans: The Global Optogenetics Market is growing at a CAGR of 16.2% during forecasting period 2022-2029. 3. What is scope of the Global Optogenetics market report? Ans: Global Optogenetics Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Optogenetics market? Ans: The important key players in the Global Optogenetics Market are – Cobolt, Coherent Inc., Gensight Biologics, Laserglow Technologies, Noldus Information Technology, Scientifica, Shanghai Laser & Optics Century Co. Ltd., The Jackson Laborator, Thorlabs Inc., Thomas RECORDING GmbH, UNC Vector Core, Addgene, and Elliot Scientific Ltd. 5. What is the study period of this market? Ans: The Global Optogenetics Market is studied from 2021 to 2029.
Global Optogenetics Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Optogenetics Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Optogenetics Market Analysis and Forecast 6.1. Optogenetics Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Optogenetics Market Analysis and Forecast, By Sensors 7.1. Introduction and Definition 7.2. Key Findings 7.3. Optogenetics Market Value Share Analysis, By Sensors 7.4. Optogenetics Market Size (US$ Bn) Forecast, By Sensors 7.5. Optogenetics Market Analysis, By Sensors 7.6. Optogenetics Market Attractiveness Analysis, By Sensors 8. Global Optogenetics Market Analysis and Forecast, By Techniques 8.1. Introduction and Definition 8.2. Key Findings 8.3. Optogenetics Market Value Share Analysis, By Techniques 8.4. Optogenetics Market Size (US$ Bn) Forecast, By Techniques 8.5. Optogenetics Market Analysis, By Techniques 8.6. Optogenetics Market Attractiveness Analysis, By Techniques 9. Global Optogenetics Market Analysis and Forecast, By Light equipment 9.1. Introduction and Definition 9.2. Key Findings 9.3. Optogenetics Market Value Share Analysis, By Light equipment 9.4. Optogenetics Market Size (US$ Bn) Forecast, By Light equipment 9.5. Optogenetics Market Analysis, By Light equipment 9.6. Optogenetics Market Attractiveness Analysis, By Light equipment 10. Global Optogenetics Market Analysis and Forecast, By Application 10.1. Introduction and Definition 10.2. Key Findings 10.3. Optogenetics Market Value Share Analysis, By Application 10.4. Optogenetics Market Size (US$ Bn) Forecast, By Application 10.5. Optogenetics Market Analysis, By Application 10.6. Optogenetics Market Attractiveness Analysis, By Application 11. Global Optogenetics Market Analysis, By Region 11.1. Optogenetics Market Value Share Analysis, by Region 11.2. Optogenetics Market Size (US$ Bn) Forecast, by Region 11.3. Optogenetics Market Attractiveness Analysis, by Region 12. North America Optogenetics Market Analysis 12.1. Key Findings 12.2. North America Optogenetics Market Overview 12.3. North America Optogenetics Market Value Share Analysis, By Sensors 12.4. North America Optogenetics Market Forecast, By Sensors 12.4.1. Genetically Modified Calcium Indicators 12.4.2. pH Sensors 12.4.3. Neurotransmitter Release 12.4.4. Voltage-sensitive Fluorescent Proteins 12.5. North America Optogenetics Market Value Share Analysis, By Techniques 12.6. North America Optogenetics Market Forecast, By Techniques 12.6.1. Channelrhodopsin 12.6.2. Halorhodopsin 12.6.3. Archaerhodopsin 12.7. North America Optogenetics Market Value Share Analysis, By Light equipment 12.8. North America Optogenetics Market Forecast, By Light equipment 12.8.1. Lasers 12.8.2. LEDs 12.8.3. Others 12.9. North America Optogenetics Market Value Share Analysis, By Application 12.10. North America Optogenetics Market Forecast, By Application 12.10.1. Retinal Disease Treatment 12.10.2. Cardiovascular Ailments 12.10.3. Neuroscience 12.10.4. Behavioral Tracking and Pacing 12.11. North America Optogenetics Market Value Share Analysis, by Country 12.12. North America Optogenetics Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Optogenetics Market Analysis, by Country 12.14. U.S. Optogenetics Market Forecast, By Sensors 12.14.1. Genetically Modified Calcium Indicators 12.14.2. pH Sensors 12.14.3. Neurotransmitter Release 12.14.4. Voltage-sensitive Fluorescent Proteins 12.15. U.S. Optogenetics Market Forecast, By Techniques 12.15.1. Channelrhodopsin 12.15.2. Halorhodopsin 12.15.3. Archaerhodopsin 12.16. U.S. Optogenetics Market Forecast, By Light equipment 12.16.1. Lasers 12.16.2. LEDs 12.16.3. Others 12.17. U.S. Optogenetics Market Forecast, By Application 12.17.1. Retinal Disease Treatment 12.17.2. Cardiovascular Ailments 12.17.3. Neuroscience 12.17.4. Behavioral Tracking and Pacing 12.18. Canada Optogenetics Market Forecast, By Sensors 12.18.1. Genetically Modified Calcium Indicators 12.18.2. pH Sensors 12.18.3. Neurotransmitter Release 12.18.4. Voltage-sensitive Fluorescent Proteins 12.19. Canada Optogenetics Market Forecast, By Techniques 12.19.1. Channelrhodopsin 12.19.2. Halorhodopsin 12.19.3. Archaerhodopsin 12.20. Canada Optogenetics Market Forecast, By Light equipment 12.20.1. Lasers 12.20.2. LEDs 12.20.3. Others 12.21. Canada Optogenetics Market Forecast, By Application 12.21.1. Retinal Disease Treatment 12.21.2. Cardiovascular Ailments 12.21.3. Neuroscience 12.21.4. Behavioral Tracking and Pacing 12.22. North America Optogenetics Market Attractiveness Analysis 12.22.1. By Sensors 12.22.2. By Techniques 12.22.3. By Light equipment 12.22.4. By Application 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe Optogenetics Market Analysis 13.1. Key Findings 13.2. Europe Optogenetics Market Overview 13.3. Europe Optogenetics Market Value Share Analysis, By Sensors 13.4. Europe Optogenetics Market Forecast, By Sensors 13.4.1. Genetically Modified Calcium Indicators 13.4.2. pH Sensors 13.4.3. Neurotransmitter Release 13.4.4. Voltage-sensitive Fluorescent Proteins 13.5. Europe Optogenetics Market Value Share Analysis, By Techniques 13.6. Europe Optogenetics Market Forecast, By Techniques 13.6.1. Channelrhodopsin 13.6.2. Halorhodopsin 13.6.3. Archaerhodopsin 13.7. Europe Optogenetics Market Value Share Analysis, By Light equipment 13.8. Europe Optogenetics Market Forecast, By Light equipment 13.8.1. Lasers 13.8.2. LEDs 13.8.3. Others 13.9. Europe Optogenetics Market Value Share Analysis, By Application 13.10. Europe Optogenetics Market Forecast, By Application 13.10.1. Retinal Disease Treatment 13.10.2. Cardiovascular Ailments 13.10.3. Neuroscience 13.10.4. Behavioral Tracking and Pacing 13.11. Europe Optogenetics Market Value Share Analysis, by Country 13.12. Europe Optogenetics Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Optogenetics Market Analysis, by Country 13.14. Germany Optogenetics Market Forecast, By Sensors 13.14.1. Genetically Modified Calcium Indicators 13.14.2. pH Sensors 13.14.3. Neurotransmitter Release 13.14.4. Voltage-sensitive Fluorescent Proteins 13.15. Germany Optogenetics Market Forecast, By Techniques 13.15.1. Channelrhodopsin 13.15.2. Halorhodopsin 13.15.3. Archaerhodopsin 13.16. Germany Optogenetics Market Forecast, By Light equipment 13.16.1. Lasers 13.16.2. LEDs 13.16.3. Others 13.17. Germany Optogenetics Market Forecast, By Application 13.17.1. Retinal Disease Treatment 13.17.2. Cardiovascular Ailments 13.17.3. Neuroscience 13.17.4. Behavioral Tracking and Pacing 13.18. U.K. Optogenetics Market Forecast, By Sensors 13.18.1. Genetically Modified Calcium Indicators 13.18.2. pH Sensors 13.18.3. Neurotransmitter Release 13.18.4. Voltage-sensitive Fluorescent Proteins 13.19. U.K. Optogenetics Market Forecast, By Techniques 13.19.1. Channelrhodopsin 13.19.2. Halorhodopsin 13.19.3. Archaerhodopsin 13.20. U.K. Optogenetics Market Forecast, By Light equipment 13.20.1. Lasers 13.20.2. LEDs 13.20.3. Others 13.21. U.K. Optogenetics Market Forecast, By Application 13.21.1. Retinal Disease Treatment 13.21.2. Cardiovascular Ailments 13.21.3. Neuroscience 13.21.4. Behavioral Tracking and Pacing 13.22. France Optogenetics Market Forecast, By Sensors 13.22.1. Genetically Modified Calcium Indicators 13.22.2. pH Sensors 13.22.3. Neurotransmitter Release 13.22.4. Voltage-sensitive Fluorescent Proteins 13.23. France Optogenetics Market Forecast, By Techniques 13.23.1. Channelrhodopsin 13.23.2. Halorhodopsin 13.23.3. Archaerhodopsin 13.24. France Optogenetics Market Forecast, By Light equipment 13.24.1. Lasers 13.24.2. LEDs 13.24.3. Others 13.25. France Optogenetics Market Forecast, By Application 13.25.1. Retinal Disease Treatment 13.25.2. Cardiovascular Ailments 13.25.3. Neuroscience 13.25.4. Behavioral Tracking and Pacing 13.26. Italy Optogenetics Market Forecast, By Sensors 13.26.1. Genetically Modified Calcium Indicators 13.26.2. pH Sensors 13.26.3. Neurotransmitter Release 13.26.4. Voltage-sensitive Fluorescent Proteins 13.27. Italy Optogenetics Market Forecast, By Techniques 13.27.1. Channelrhodopsin 13.27.2. Halorhodopsin 13.27.3. Archaerhodopsin 13.28. Italy Optogenetics Market Forecast, By Light equipment 13.28.1. Lasers 13.28.2. LEDs 13.28.3. Others 13.29. Italy Optogenetics Market Forecast, By Application 13.29.1. Retinal Disease Treatment 13.29.2. Cardiovascular Ailments 13.29.3. Neuroscience 13.29.4. Behavioral Tracking and Pacing 13.30. Spain Optogenetics Market Forecast, By Sensors 13.30.1. Genetically Modified Calcium Indicators 13.30.2. pH Sensors 13.30.3. Neurotransmitter Release 13.30.4. Voltage-sensitive Fluorescent Proteins 13.31. Spain Optogenetics Market Forecast, By Techniques 13.31.1. Channelrhodopsin 13.31.2. Halorhodopsin 13.31.3. Archaerhodopsin 13.32. Spain Optogenetics Market Forecast, By Light equipment 13.32.1. Lasers 13.32.2. LEDs 13.32.3. Others 13.33. Spain Optogenetics Market Forecast, By Application 13.33.1. Retinal Disease Treatment 13.33.2. Cardiovascular Ailments 13.33.3. Neuroscience 13.33.4. Behavioral Tracking and Pacing 13.34. Rest of Europe Optogenetics Market Forecast, By Sensors 13.34.1. Genetically Modified Calcium Indicators 13.34.2. pH Sensors 13.34.3. Neurotransmitter Release 13.34.4. Voltage-sensitive Fluorescent Proteins 13.35. Rest of Europe Optogenetics Market Forecast, By Techniques 13.35.1. Channelrhodopsin 13.35.2. Halorhodopsin 13.35.3. Archaerhodopsin 13.36. Rest of Europe Optogenetics Market Forecast, By Light equipment 13.36.1. Lasers 13.36.2. LEDs 13.36.3. Others 13.37. Rest Of Europe Optogenetics Market Forecast, By Application 13.37.1. Retinal Disease Treatment 13.37.2. Cardiovascular Ailments 13.37.3. Neuroscience 13.37.4. Behavioral Tracking and Pacing 13.38. Europe Optogenetics Market Attractiveness Analysis 13.38.1. By Sensors 13.38.2. By Techniques 13.38.3. By Light equipment 13.38.4. By Application 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Developments 14. Asia Pacific Optogenetics Market Analysis 14.1. Key Findings 14.2. Asia Pacific Optogenetics Market Overview 14.3. Asia Pacific Optogenetics Market Value Share Analysis, By Sensors 14.4. Asia Pacific Optogenetics Market Forecast, By Sensors 14.4.1. Genetically Modified Calcium Indicators 14.4.2. pH Sensors 14.4.3. Neurotransmitter Release 14.4.4. Voltage-sensitive Fluorescent Proteins 14.5. Asia Pacific Optogenetics Market Value Share Analysis, By Techniques 14.6. Asia Pacific Optogenetics Market Forecast, By Techniques 14.6.1. Channelrhodopsin 14.6.2. Halorhodopsin 14.6.3. Archaerhodopsin 14.7. Asia Pacific Optogenetics Market Value Share Analysis, By Light equipment 14.8. Asia Pacific Optogenetics Market Forecast, By Light equipment 14.8.1. Lasers 14.8.2. LEDs 14.8.3. Others 14.9. Asia Pacific Optogenetics Market Value Share Analysis, By Application 14.10. Asia Pacific Optogenetics Market Forecast, By Application 14.10.1. Retinal Disease Treatment 14.10.2. Cardiovascular Ailments 14.10.3. Neuroscience 14.10.4. Behavioral Tracking and Pacing 14.11. Asia Pacific Optogenetics Market Value Share Analysis, by Country 14.12. Asia Pacific Optogenetics Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Optogenetics Market Analysis, by Country 14.14. China Optogenetics Market Forecast, By Sensors 14.14.1. Genetically Modified Calcium Indicators 14.14.2. pH Sensors 14.14.3. Neurotransmitter Release 14.14.4. Voltage-sensitive Fluorescent Proteins 14.15. China Optogenetics Market Forecast, By Techniques 14.15.1. Channelrhodopsin 14.15.2. Halorhodopsin 14.15.3. Archaerhodopsin 14.16. China Optogenetics Market Forecast, By Light equipment 14.16.1. Lasers 14.16.2. LEDs 14.16.3. Others 14.17. China Optogenetics Market Forecast, By Application 14.17.1. Retinal Disease Treatment 14.17.2. Cardiovascular Ailments 14.17.3. Neuroscience 14.17.4. Behavioral Tracking and Pacing 14.18. India Optogenetics Market Forecast, By Sensors 14.18.1. Genetically Modified Calcium Indicators 14.18.2. pH Sensors 14.18.3. Neurotransmitter Release 14.18.4. Voltage-sensitive Fluorescent Proteins 14.19. India Optogenetics Market Forecast, By Techniques 14.19.1. Channelrhodopsin 14.19.2. Halorhodopsin 14.19.3. Archaerhodopsin 14.20. India Optogenetics Market Forecast, By Light equipment 14.20.1. Lasers 14.20.2. LEDs 14.20.3. Others 14.21. India Optogenetics Market Forecast, By Application 14.21.1. Retinal Disease Treatment 14.21.2. Cardiovascular Ailments 14.21.3. Neuroscience 14.21.4. Behavioral Tracking and Pacing 14.22. Japan Optogenetics Market Forecast, By Sensors 14.22.1. Genetically Modified Calcium Indicators 14.22.2. pH Sensors 14.22.3. Neurotransmitter Release 14.22.4. Voltage-sensitive Fluorescent Proteins 14.23. Japan Optogenetics Market Forecast, By Techniques 14.23.1. Channelrhodopsin 14.23.2. Halorhodopsin 14.23.3. Archaerhodopsin 14.24. Japan Optogenetics Market Forecast, By Light equipment 14.24.1. Lasers 14.24.2. LEDs 14.24.3. Others 14.25. Japan Optogenetics Market Forecast, By Application 14.25.1. Retinal Disease Treatment 14.25.2. Cardiovascular Ailments 14.25.3. Neuroscience 14.25.4. Behavioral Tracking and Pacing 14.26. ASEAN Optogenetics Market Forecast, By Sensors 14.26.1. Genetically Modified Calcium Indicators 14.26.2. pH Sensors 14.26.3. Neurotransmitter Release 14.26.4. Voltage-sensitive Fluorescent Proteins 14.27. ASEAN Optogenetics Market Forecast, By Techniques 14.27.1. Channelrhodopsin 14.27.2. Halorhodopsin 14.27.3. Archaerhodopsin 14.28. ASEAN Optogenetics Market Forecast, By Light equipment 14.28.1. Lasers 14.28.2. LEDs 14.28.3. Others 14.29. ASEAN Optogenetics Market Forecast, By Application 14.29.1. Retinal Disease Treatment 14.29.2. Cardiovascular Ailments 14.29.3. Neuroscience 14.29.4. Behavioral Tracking and Pacing 14.30. Rest of Asia Pacific Optogenetics Market Forecast, By Sensors 14.30.1. Genetically Modified Calcium Indicators 14.30.2. pH Sensors 14.30.3. Neurotransmitter Release 14.30.4. Voltage-sensitive Fluorescent Proteins 14.31. Rest of Asia Pacific Optogenetics Market Forecast, By Techniques 14.31.1. Channelrhodopsin 14.31.2. Halorhodopsin 14.31.3. Archaerhodopsin 14.32. Rest of Asia Pacific Optogenetics Market Forecast, By Light equipment 14.32.1. Lasers 14.32.2. LEDs 14.32.3. Others 14.33. Rest of Asia Pacific Optogenetics Market Forecast, By Application 14.33.1. Retinal Disease Treatment 14.33.2. Cardiovascular Ailments 14.33.3. Neuroscience 14.33.4. Behavioral Tracking and Pacing 14.34. Asia Pacific Optogenetics Market Attractiveness Analysis 14.34.1. By Sensors 14.34.2. By Techniques 14.34.3. By Light equipment 14.34.4. By Application 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa Optogenetics Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Optogenetics Market Overview 15.3. Middle East & Africa Optogenetics Market Value Share Analysis, By Sensors 15.4. Middle East & Africa Optogenetics Market Forecast, By Sensors 15.4.1. Genetically Modified Calcium Indicators 15.4.2. pH Sensors 15.4.3. Neurotransmitter Release 15.4.4. Voltage-sensitive Fluorescent Proteins 15.5. Middle East & Africa Optogenetics Market Value Share Analysis, By Techniques 15.6. Middle East & Africa Optogenetics Market Forecast, By Techniques 15.6.1. Channelrhodopsin 15.6.2. Halorhodopsin 15.6.3. Archaerhodopsin 15.7. Middle East & Africa Optogenetics Market Value Share Analysis, By Light equipment 15.8. Middle East & Africa Optogenetics Market Forecast, By Light equipment 15.8.1. Lasers 15.8.2. LEDs 15.8.3. Others 15.9. Middle East & Africa Optogenetics Market Value Share Analysis, By Application 15.10. Middle East & Africa Optogenetics Market Forecast, By Application 15.10.1. Retinal Disease Treatment 15.10.2. Cardiovascular Ailments 15.10.3. Neuroscience 15.10.4. Behavioral Tracking and Pacing 15.11. Middle East & Africa Optogenetics Market Value Share Analysis, by Country 15.12. Middle East & Africa Optogenetics Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Optogenetics Market Analysis, by Country 15.14. GCC Optogenetics Market Forecast, By Sensors 15.14.1. Genetically Modified Calcium Indicators 15.14.2. pH Sensors 15.14.3. Neurotransmitter Release 15.14.4. Voltage-sensitive Fluorescent Proteins 15.15. GCC Optogenetics Market Forecast, By Techniques 15.15.1. Channelrhodopsin 15.15.2. Halorhodopsin 15.15.3. Archaerhodopsin 15.16. GCC Optogenetics Market Forecast, By Light equipment 15.16.1. Lasers 15.16.2. LEDs 15.16.3. Others 15.17. GCC Optogenetics Market Forecast, By Application 15.17.1. Retinal Disease Treatment 15.17.2. Cardiovascular Ailments 15.17.3. Neuroscience 15.17.4. Behavioral Tracking and Pacing 15.18. South Africa Optogenetics Market Forecast, By Sensors 15.18.1. Genetically Modified Calcium Indicators 15.18.2. pH Sensors 15.18.3. Neurotransmitter Release 15.18.4. Voltage-sensitive Fluorescent Proteins 15.19. South Africa Optogenetics Market Forecast, By Techniques 15.19.1. Channelrhodopsin 15.19.2. Halorhodopsin 15.19.3. Archaerhodopsin 15.20. South Africa Optogenetics Market Forecast, By Light equipment 15.20.1. Lasers 15.20.2. LEDs 15.20.3. Others 15.21. South Africa Optogenetics Market Forecast, By Application 15.21.1. Retinal Disease Treatment 15.21.2. Cardiovascular Ailments 15.21.3. Neuroscience 15.21.4. Behavioral Tracking and Pacing 15.22. Rest of Middle East & Africa Optogenetics Market Forecast, By Sensors 15.22.1. Genetically Modified Calcium Indicators 15.22.2. pH Sensors 15.22.3. Neurotransmitter Release 15.22.4. Voltage-sensitive Fluorescent Proteins 15.23. Rest of Middle East & Africa Optogenetics Market Forecast, By Techniques 15.23.1. Channelrhodopsin 15.23.2. Halorhodopsin 15.23.3. Archaerhodopsin 15.24. Rest of Middle East & Africa Optogenetics Market Forecast, By Light equipment 15.24.1. Lasers 15.24.2. LEDs 15.24.3. Others 15.25. Rest of Middle East & Africa Optogenetics Market Forecast, By Application 15.25.1. Retinal Disease Treatment 15.25.2. Cardiovascular Ailments 15.25.3. Neuroscience 15.25.4. Behavioral Tracking and Pacing 15.26. Middle East & Africa Optogenetics Market Attractiveness Analysis 15.26.1. By Sensors 15.26.2. By Techniques 15.26.3. By Light equipment 15.26.4. By Application 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America Optogenetics Market Analysis 16.1. Key Findings 16.2. South America Optogenetics Market Overview 16.3. South America Optogenetics Market Value Share Analysis, By Sensors 16.4. South America Optogenetics Market Forecast, By Sensors 16.4.1. Genetically Modified Calcium Indicators 16.4.2. pH Sensors 16.4.3. Neurotransmitter Release 16.4.4. Voltage-sensitive Fluorescent Proteins 16.5. South America Optogenetics Market Value Share Analysis, By Techniques 16.6. South America Optogenetics Market Forecast, By Techniques 16.6.1. Channelrhodopsin 16.6.2. Halorhodopsin 16.6.3. Archaerhodopsin 16.7. South America Optogenetics Market Value Share Analysis, By Light equipment 16.8. South America Optogenetics Market Forecast, By Light equipment 16.8.1. Lasers 16.8.2. LEDs 16.8.3. Others 16.9. South America Optogenetics Market Value Share Analysis, By Application 16.10. South America Optogenetics Market Forecast, By Application 16.10.1. Retinal Disease Treatment 16.10.2. Cardiovascular Ailments 16.10.3. Neuroscience 16.10.4. Behavioral Tracking and Pacing 16.11. South America Optogenetics Market Value Share Analysis, by Country 16.12. South America Optogenetics Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Optogenetics Market Analysis, by Country 16.14. Brazil Optogenetics Market Forecast, By Sensors 16.14.1. Genetically Modified Calcium Indicators 16.14.2. pH Sensors 16.14.3. Neurotransmitter Release 16.14.4. Voltage-sensitive Fluorescent Proteins 16.15. Brazil Optogenetics Market Forecast, By Techniques 16.15.1. Channelrhodopsin 16.15.2. Halorhodopsin 16.15.3. Archaerhodopsin 16.16. Brazil Optogenetics Market Forecast, By Light equipment 16.16.1. Lasers 16.16.2. LEDs 16.16.3. Others 16.17. Brazil Optogenetics Market Forecast, By Application 16.17.1. Retinal Disease Treatment 16.17.2. Cardiovascular Ailments 16.17.3. Neuroscience 16.17.4. Behavioral Tracking and Pacing 16.18. Mexico Optogenetics Market Forecast, By Sensors 16.18.1. Genetically Modified Calcium Indicators 16.18.2. pH Sensors 16.18.3. Neurotransmitter Release 16.18.4. Voltage-sensitive Fluorescent Proteins 16.19. Mexico Optogenetics Market Forecast, By Techniques 16.19.1. Channelrhodopsin 16.19.2. Halorhodopsin 16.19.3. Archaerhodopsin 16.20. Mexico Optogenetics Market Forecast, By Light equipment 16.20.1. Lasers 16.20.2. LEDs 16.20.3. Others 16.21. Mexico Optogenetics Market Forecast, By Application 16.21.1. Retinal Disease Treatment 16.21.2. Cardiovascular Ailments 16.21.3. Neuroscience 16.21.4. Behavioral Tracking and Pacing 16.22. Rest of South America Optogenetics Market Forecast, By Sensors 16.22.1. Genetically Modified Calcium Indicators 16.22.2. pH Sensors 16.22.3. Neurotransmitter Release 16.22.4. Voltage-sensitive Fluorescent Proteins 16.23. Rest of South America Optogenetics Market Forecast, By Techniques 16.23.1. Channelrhodopsin 16.23.2. Halorhodopsin 16.23.3. Archaerhodopsin 16.24. Rest of South America Optogenetics Market Forecast, By Light equipment 16.24.1. Lasers 16.24.2. LEDs 16.24.3. Others 16.25. Rest of South America Optogenetics Market Forecast, By Application 16.25.1. Retinal Disease Treatment 16.25.2. Cardiovascular Ailments 16.25.3. Neuroscience 16.25.4. Behavioral Tracking and Pacing 16.26. South America Optogenetics Market Attractiveness Analysis 16.26.1. By Sensors 16.26.2. By Techniques 16.26.3. By Light equipment 16.26.4. By Application 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.4. M&A by Regions, Investment and Applications 17.2.5. M&A Key Players, Forward Integration and Backward 17.2.6. Integration 17.3. Company Profiles: Key Players 17.3.1. Cobolt 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Development Footprint 17.3.2. Coherent Inc. 17.3.3. Gensight Biologics 17.3.4. Laserglow Technologies 17.3.5. Noldus Information Technology 17.3.6. Scientifica 17.3.7. Shanghai Laser & Optics Century Co. Ltd. 17.3.8. The Jackson Laborator 17.3.9. Thorlabs Inc. 17.3.10. Thomas RECORDING GmbH 17.3.11. UNC Vector Core 17.3.12. Addgene 17.3.13. Elliot Scientific Ltd. 17.3.14. Danaher 17.3.15. Prizmatix 17.3.16. Bruker 17.3.17. Judges Scientific plc 17.3.18. Merck KGaA 17.3.19. Circuit Therapeutics, Inc 18. Primary Key Insights